NRXS

Neuraxis, INC

Latest Form 4:Purchase$16KbyCarrico Brian Allen (Chief Executive Officer) · filed Apr 3, 2026

Neuraxis, INC (NRXS) has 19 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Aug 26, 2026.

  • Industry:Biotechnology
  • CEO:Brian Carrico
  • Employees:21
  • HQ:Carmel, IN, US
  • IPO:2023-08-09

Insider Buying

$1.0M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Market Cap

$74.8M

latest known value

Source
Purchase$16KApr 3SEC ↗
Purchase$15KApr 3SEC ↗
Purchase$1KApr 3SEC ↗
Aharon GilFirst filing
Purchase$1.0MDec 29SEC ↗

Related companies

Neuraxis, INC is in the Healthcare sector.